Karin Lehrich
Papers
2
Total Citations
252
H-Index
2
About
Karin Lehrich is a pioneering urological surgeon whose work has fundamentally shaped the surgical management of benign prostatic hyperplasia (BPH), particularly for patients with extremely large prostate glands. Her landmark 2002 study, a randomized prospective trial of 120 patients, established transurethral holmium laser enucleation (HoLEP) as a safe and effective alternative to open surgery for prostates exceeding 100 grams—a procedure that was previously considered the exclusive domain of open enucleation. With 250 citations, this work remains a cornerstone in the field, demonstrating that HoLEP offers comparable efficacy with significantly reduced morbidity. Lehrich’s ongoing research continues to push boundaries, addressing the most challenging cases: prostates larger than 200 ml. Her recent 2024 publication critically evaluates whether endoscopic, robotic, or open approaches are optimal for these extreme volumes, highlighting the persistent lack of robust data. Through her rigorous clinical trials and comparative effectiveness studies, Lehrich has not only advanced surgical technique but also provided the evidence base that guides urologists in selecting the safest, most effective interventions for patients with massive prostatic adenomas.
Research Focus
Key Achievements
Top Papers
- 1
- 2